The new diagnostic, which relies on CRISPR technology, can be assembled for about $15, but those costs could come down significantly if the devices were produced at large scale.
read more
On Monday, the U.S. Food and Drug Administration granted full approval to Pfizer and BioNTech's COVID-19 vaccine, making it the first in the country to move beyond Emergency Use Authorization.
read more
Researchers have discovered how glycans—molecules that make up a sugary residue around the edges of the spike protein—act as infection gateways.
read more
For the first time in live animals, researchers have captured on video the spread of SARS-CoV-2, tracing the virus as it moved from the noses of infected mice to the lungs, other organs and eventually the brain.
read more
Scientists have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.
read more